REG - Sunplus Technology - Half-year Report

Sunplus Technology CoAnnouncement

13/08/2019 11:20

RNS Number : 8767I
Sunplus Technology Co Limited
13 August 2019
 


Sunplus Technology Company Limited
Consolidated Balance Sheets
Ended June 30, 2019*
(In Thousands of New Taiwan Dollars)
 



Assets


Amount


Liabilities & Shareholders Equity


Amount




Cash & Equivalent


2,977,774


Current Liabilities


2,073,422




Financial assets at fair value through profit or loss-current 


1,467,264


Non-Current Liabilities


594,706




Accounts & Notes receivable


1,107,268


Total Liabilities


2,668,128




Other Receivable


86,898


Equity attributable to owners of the parent








Inventories


791,828


Capital stock


5,919,949




Other current assets


284,103


Shares to be issued








Total Current Assets


6,715,135


Capital surplus


594,353












Appropriated as legal reserve


1,942,388




Financial assets at fair value through profit or loss - non-current


793,257


Appropriated as special reserve


308,452




Financial assets at fair value through other comprehensive income t - non-current


282,453


Unappropriated earnings (deficit)


10,453




Investments accounted for using the equity method


706,197


Others


(409,990)




Property, plant and equipment


2,065,919


Treasury Stock


(63,401)




Right-of-use asset


348,607


Total equity attributable to owners of the parent


8,302,204




Investment properties


1,015,677












Intangible Assets-Net


176,585


Non-Controlling Interests


1,335,802




Deferred tax assets


30,264


Total Shareholders¡¦ Equity


9,638,006




Other Non-Current Assets


172,040












Total Non-Current Investments


5,590,999












Total Assets


        12,306,134


Total Liabilities & Shareholders' Equity


12,306,134







 
Sunplus Technology Company Limited
Consolidated Statements of Income
From January 1 to June 30, 2019 and 2018
(In Thousands of New Taiwan Dollars, Except Earnings per share) 



Unit: NT$K, Except EPS


2019


2018


YoY




Net sales


2,711,351


3,228,232


(16.01)




Cost


1,561,135


1,983,518


(21.29)




Gross Profit


1,150,216


1,244,714


(7.59)




  Marketing Expense


137,333


154,732


(11.24)




  General& Administrative Expense


247,929


269,349


(7.95)




R&D Expenses


736,339


920,865


(20.04)




Expected credit losses


211


-


-




Other operating income(Expense)


143


15


853.33




Total operating income (expense)


28,547


(100,217)


(128.49)




Total non-operating income (expense)


96,495


182,270


(47.06)




Income(loss) before income tax from continued operating units


125,042


82,053


52.39




Income tax expense


25,560


31,117


(17.86)




Consolidated Net Income


99,482


50,936


95.31




Consolidated Net Income

Attributable To Shareholders of the parent


13,332


(13,791)


(196.67)




Consolidated Earnings Per Share NT$ Attributable To Shareholders of the parent*


0.02


(0.02)







* Based on outstanding 588,434,923 shares on 2019/06/30




Sunplus Technology Company Limited
Consolidated Cash Flow Summary
From January 1 to June 30, 2019 and 2018
(In Thousand New Taiwan Dollars)
 



ITEM


2019


2018




Cash Flow in (out) from operating


181,247


(60,540)




Cash Flow in (out) from Investing


(292,790)


(511,253)




Cash Flow in (out) from Financing


(150,169)


(135,585)




Impact from Fx Change


3,765


6,343




Net Increase (Decrease) in Cash & Cash Equivalents


(257,947)


(701,035)




Cash & Cash Equivalents, Beginning of Period


3,235,721


4,156,277




Cash & Cash Equivalents, End of Period


2,977,774


3,455,242



 
 




Spokesman
Wayne Shen
Tel: +886-3-5786005 ext. 2350
E-mail: wayne@sunplus.com
 


 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR LLFLITLIVLIA